Back to ALL Research Publications
Research Category: Advanced Therapies
Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study
Find out how to make a difference in wound care
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
Global
USA
©2023
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.